Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


25.02.2019

1 Ann Surg Oncol
1 Biomed Pharmacother
1 Biosci Rep
1 Biosens Bioelectron
1 Cancer Lett
1 Clin Radiol
1 Exp Cell Res
1 Exp Ther Med
1 Expert Rev Vaccines
1 Front Pharmacol
3 Geburtshilfe Frauenheilkd
2 Gynecol Oncol
1 Indian J Med Res
1 Int J Biol Macromol
1 Int J Mol Sci
1 J Biomol Struct Dyn
1 J Cancer Educ
2 J Cell Physiol
1 J Exp Clin Cancer Res
2 J Low Genit Tract Dis
1 J Obstet Gynaecol Res
1 J Radiat Res
1 Magn Reson Med Sci
4 N Engl J Med
1 Nan Fang Yi Ke Da Xue Xue Bao
1 Onco Targets Ther
1 Oncogene
1 Phys Med
1 Prev Chronic Dis
2 Rev Bras Ginecol Obstet
1 Rev Esp Patol
1 Sheng Wu Gong Cheng Xue Bao
1 Tex Med
3 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. CASARIN J, Multinu F, Pasupathy K, Weaver A, et al
    Frozen Section for Detection of Lymph Nodes After Cervical Injection with Indocyanine Green (ICG) for Sentinel Lymph Node Technique in Endometrial Cancer Staging.
    Ann Surg Oncol. 2018;25:3692-3698.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  2. XIONG Y, Li T, Assani G, Ling H, et al
    Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo.
    Biomed Pharmacother. 2019;112:108602.
    PubMed     Text format     Abstract available


    Biosci Rep

  3. LIU S, Meng F, Ding J, Ji H, et al
    High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer.
    Biosci Rep. 2019 Feb 21. pii: BSR20181639. doi: 10.1042/BSR20181639.
    PubMed     Text format     Abstract available


    Biosens Bioelectron

  4. OBAHIAGBON U, Smith JT, Zhu M, Katchman BA, et al
    A compact, low-cost, quantitative and multiplexed fluorescence detection platform for point-of-care applications.
    Biosens Bioelectron. 2018;117:153-160.
    PubMed     Text format     Abstract available


    Cancer Lett

  5. VLIET-GREGG PA, Robinson KL, Levan J, Matsumoto LR, et al
    NFX1-123 is highly expressed in cervical cancer and increases growth and telomerase activity in HPV 16E6 expressing cells.
    Cancer Lett. 2019 Feb 15. pii: S0304-3835(19)30102.
    PubMed     Text format     Abstract available


    Clin Radiol

  6. NAKAO KK, Kido A, Imai T, Abiko K, et al
    Frequency and risk factors of thoracic metastases and optimisation of the use of cross-sectional chest imaging in follow-up patients with cervical cancer.
    Clin Radiol. 2019 Feb 13. pii: S0009-9260(19)30062.
    PubMed     Text format     Abstract available


    Exp Cell Res

  7. RODRIGUES C, Pattabiraman C, Vijaykumar A, Arora R, et al
    A SUV39H1-low chromatin state characterises and promotes migratory properties of cervical cancer cells.
    Exp Cell Res. 2019 Feb 14. pii: S0014-4827(18)30986.
    PubMed     Text format     Abstract available


    Exp Ther Med

  8. ZHANG Q, Yang D
    Allicin suppresses the migration and invasion in cervical cancer cells mainly by inhibiting NRF2.
    Exp Ther Med. 2019;17:1523-1528.
    PubMed     Text format     Abstract available


    Expert Rev Vaccines

  9. LYNGE E, Skorstengaard M, Lubker CL, Thamsborg L, et al
    HPV-vaccination impact in Denmark: is the vaccine working?
    Expert Rev Vaccines. 2018;17:765-767.
    PubMed     Text format    


    Front Pharmacol

  10. LIU Y, Wu L, Tong R, Yang F, et al
    PD-1/PD-L1 Inhibitors in Cervical Cancer.
    Front Pharmacol. 2019;10:65.
    PubMed     Text format     Abstract available


    Geburtshilfe Frauenheilkd

  11. HILLEMANNS P, Friese K, Dannecker C, Klug S, et al
    Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up.
    Geburtshilfe Frauenheilkd. 2019;79:160-176.
    PubMed     Text format     Abstract available

  12. HILLEMANNS P, Brucker S, Holthaus B, Kimmig R, et al
    Updated Opinion of the Uterus Commission of the Gynecological Oncology Working Group (AGO) and the Gynecological Endoscopy Working Group (AGE) of the German Society of Gynecology and Obstetrics (DGGG) on the Randomized Study Comparing Minimally Invasi
    Geburtshilfe Frauenheilkd. 2019;79:145-147.
    PubMed     Text format     Abstract available

  13. HILLEMANNS P, Friese K, Dannecker C, Klug S, et al
    Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
    Geburtshilfe Frauenheilkd. 2019;79:148-159.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  14. EINSTEIN MH, Ndlovu N, Lee J, Stier EA, et al
    Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortium.
    Gynecol Oncol. 2019 Feb 15. pii: S0090-8258(19)30065.
    PubMed     Text format     Abstract available

  15. XIA P, Huang M, Zhang Y, Xiong X, et al
    NCK1 promotes the angiogenesis of cervical squamous carcinoma via Rac1/PAK1/MMP2 signal pathway.
    Gynecol Oncol. 2019;152:387-395.
    PubMed     Text format     Abstract available


    Indian J Med Res

  16. SRIVASTAVA AN, Misra JS, Srivastava S, Das BC, et al
    Cervical cancer screening in rural India: Status & current concepts.
    Indian J Med Res. 2018;148:687-696.
    PubMed     Text format     Abstract available


    Int J Biol Macromol

  17. XU Y, Zhou W, Zhang C, Liu X, et al
    Long non-coding RNA RP11-552M11.4 favors tumorigenesis and development of cervical cancer via modulating miR-3941/ATF1 signaling.
    Int J Biol Macromol. 2019 Feb 18. pii: S0141-8130(18)36758.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  18. LI X, Cai Y
    Methylation-Based Classification of Cervical Squamous Cell Carcinoma into Two New Subclasses Differing in Immune-Related Gene Expression.
    Int J Mol Sci. 2018;19.
    PubMed     Text format     Abstract available


    J Biomol Struct Dyn

  19. CHAUDHARY M, Kumar N, Baldi A, Chandra R, et al
    Chloro and Bromo-Pyrazole Curcumin Knoevenagel Condensates augmented Anticancer activity against Human Cervical Cancer Cells: Design, Synthesis, In silico Docking and In Vitro Cytotoxicity Analysis.
    J Biomol Struct Dyn. 2019 Feb 20:1-24. doi: 10.1080/07391102.2019.1578264.
    PubMed     Text format     Abstract available


    J Cancer Educ

  20. RICHARDS C, Thomas-Purcell KB, Vemulapalli KC, Primus-Joseph M, et al
    Woman to Woman: Implementation of a Cervical Cancer Education Training Program for Grenadian Lay Health Advisors.
    J Cancer Educ. 2019 Feb 20. pii: 10.1007/s13187-019-01495.
    PubMed     Text format     Abstract available


    J Cell Physiol

  21. GUAN YH, Tian M, Liu XY, Wang YN, et al
    Preparation of novel cisplatin-conjugated hollow gold nanospheres for targeting cervical cancer.
    J Cell Physiol. 2019 Feb 20. doi: 10.1002/jcp.28316.
    PubMed     Text format     Abstract available

  22. PERRONE AM, Bovicelli A, D'Andrilli G, Borghese G, et al
    Cervical cancer in pregnancy: Analysis of the literature and innovative approaches.
    J Cell Physiol. 2019 Feb 20. doi: 10.1002/jcp.28340.
    PubMed     Text format     Abstract available


    J Exp Clin Cancer Res

  23. WANG L, Liu Y, Zhou Y, Wang J, et al
    Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    J Exp Clin Cancer Res. 2019;38:93.
    PubMed     Text format     Abstract available


    J Low Genit Tract Dis

  24. LIANG Y, Lu B, Zhou C
    Cervical Adenoid Basal Carcinoma: Clinicopathologic Features of 9 Cases With Reference to CK17 and Ki-67 Expression.
    J Low Genit Tract Dis. 2019;23:77-81.
    PubMed     Text format     Abstract available

  25. DEMARQUET E, Mancini J, Preaubert L, Gondry J, et al
    Risk Factors of Post-Large Loop Excision of the Transformation Zone Recurrent High-Grade Cervical Intraepithelial Lesion: A Prospective Cohort Study.
    J Low Genit Tract Dis. 2019;23:18-23.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol Res

  26. TAKAHASHI Y, Matsushima H, Mori T, Kokabu T, et al
    Retroperitoneal fibrosis after chemo-radiotherapy for cervical cancer: A case report.
    J Obstet Gynaecol Res. 2019 Feb 20. doi: 10.1111/jog.13898.
    PubMed     Text format     Abstract available


    J Radiat Res

  27. HAN C, Yu W, Zheng X, Zhou Y, et al
    Composite QA for intensity-modulated radiation therapy using individual volume-based 3D gamma indices.
    J Radiat Res. 2018;59:669-676.
    PubMed     Text format     Abstract available


    Magn Reson Med Sci

  28. KATO H, Esaki K, Yamaguchi T, Tanaka H, et al
    Predicting Early Response to Chemoradiotherapy for Uterine Cervical Cancer Using Intravoxel Incoherent Motion MR Imaging.
    Magn Reson Med Sci. 2019 Feb 19. doi: 10.2463/mrms.tn.2018-0138.
    PubMed     Text format     Abstract available


    N Engl J Med

  29. ABDOLLAH F, Keeley J, Menon M
    Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer.
    N Engl J Med. 2019;380:793.
    PubMed     Text format    

  30. RAMIREZ PT, Obermair A
    Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer. Reply.
    N Engl J Med. 2019;380:794-795.
    PubMed     Text format    

  31. CHIVA L, Cibula D, Querleu D
    Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer.
    N Engl J Med. 2019;380:793-4.
    PubMed     Text format    

  32. GIL-MORENO A, Magrina JF
    Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer.
    N Engl J Med. 2019;380:794.
    PubMed     Text format    


    Nan Fang Yi Ke Da Xue Xue Bao

  33. MAI YH, Kong FT, Yang YW, Li YB, et al
    [Constraint priority list-based multi-objective optimization for intensity-modulated radiation therapy].
    Nan Fang Yi Ke Da Xue Xue Bao. 2018;38:691-697.
    PubMed     Text format     Abstract available


    Onco Targets Ther

  34. ZHAO L, Zheng Y, Ji Y, Zhang X, et al
    The expression of special AT-rich binding protein 1 in cervical cancer and its clinical significance.
    Onco Targets Ther. 2019;12:945-951.
    PubMed     Text format     Abstract available


    Oncogene

  35. WUSTENHAGEN E, Boukhallouk F, Negwer I, Rajalingam K, et al
    The Myb-related protein MYPOP is a novel intrinsic host restriction factor of oncogenic human papillomaviruses.
    Oncogene. 2018;37:6275-6284.
    PubMed     Text format     Abstract available


    Phys Med

  36. SPAMPINATO S, Fokdal L, Marinovskij E, Axelsen S, et al
    Assessment of dose to functional sub-structures in the lower urinary tract in locally advanced cervical cancer radiotherapy.
    Phys Med. 2019 Feb 13. pii: S1120-1797(19)30017.
    PubMed     Text format     Abstract available


    Prev Chronic Dis

  37. HOLZHAUSER C, Da Rosa P, Michael S
    Forecasting Participants in the All Women Count! Mammography Program.
    Prev Chronic Dis. 2018;15:E130.
    PubMed     Text format     Abstract available


    Rev Bras Ginecol Obstet


  38. International Federation of Gynecology and Obstetrics Global Declaration on Cervical Cancer Elimination.
    Rev Bras Ginecol Obstet. 2019;41:102-103.
    PubMed     Text format    

  39. CAIN JM
    Answering the Call to Accelerate the Elimination of Cervical Cancer.
    Rev Bras Ginecol Obstet. 2019;41:67.
    PubMed     Text format    


    Rev Esp Patol

  40. ABOLAFIA-CANETE B, Monserrat-Jordan JA, Cuevas-Cruces J, Arjona-Berral JE, et al
    [Early diagnosis of cervix cancer: Correlation between cytology, colposcopy and biopsy].
    Rev Esp Patol. 2018;51:147-153.
    PubMed     Text format     Abstract available


    Sheng Wu Gong Cheng Xue Bao

  41. LI W, Shi D, Jia R, Yang J, et al
    [Selection of DNA aptamers to cervical intraepithelial neoplasia by SELEX].
    Sheng Wu Gong Cheng Xue Bao. 2018;34:785-793.
    PubMed     Text format     Abstract available


    Tex Med

  42. PRICE S
    Talk to Patients About: HPV.
    Tex Med. 2018;114:46.
    PubMed     Text format     Abstract available


    Vaccine

  43. WOLFF E, Elfstrom KM, Haugen Cange H, Larsson S, et al
    Cost-effectiveness of sex-neutral HPV-vaccination in Sweden, accounting for herd-immunity and sexual behaviour.
    Vaccine. 2018 Jul 14. pii: S0264-410X(18)30948.
    PubMed     Text format     Abstract available

  44. EASTERLY CW, Alarid-Escudero F, Enns EA, Kulasingam S, et al
    Revisiting assumptions about age-based mixing representations in mathematical models of sexually transmitted infections.
    Vaccine. 2018;36:5572-5579.
    PubMed     Text format     Abstract available

  45. SKUFCA J, Ollgren J, Artama M, Ruokokoski E, et al
    The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)30925.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: